Immediate Impact
21 standout
Citing Papers
Multi-OMICS approaches in cancer biology: New era in cancer therapy
2024 Standout
HER2-targeted therapies in cancer: a systematic review
2024 Standout
Works of Aurélie Scriva being referenced
Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study
2013
Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study.
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Aurélie Scriva | 50 | 38 | 18 | 5 | 62 | |
| Petra Flygare | 37 | 34 | 23 | 7 | 70 | |
| Miriam Ahlborn | 54 | 55 | 17 | 6 | 89 | |
| Nathania Sutandi | 47 | 35 | 40 | 7 | 75 | |
| Fabiana Sousa | 24 | 31 | 18 | 8 | 52 | |
| Emily Prince | 62 | 31 | 20 | 4 | 71 | |
| Vincenzo Guarini | 55 | 18 | 9 | 4 | 68 | |
| Maria Kuiper | 85 | 40 | 21 | 5 | 102 | |
| H.W. Hoffmanns | 97 | 27 | 64 | 5 | 109 | |
| P.D.J. Hardman | 24 | 32 | 21 | 6 | 77 | |
| Lyra Del Rosario | 37 | 26 | 37 | 6 | 83 |
All Works
Loading papers...